Is EINECS 255-706-3 Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use EINECS 255-706-3? Is EINECS 255-706-3 safe for nursing mother and child? Does EINECS 255-706-3 extracts into breast milk? Does EINECS 255-706-3 has any long term or short term side effects on infants? Can EINECS 255-706-3 influence milk supply or can EINECS 255-706-3 decrease milk supply in lactating mothers?

• DrLact safety Score for EINECS 255-706-3 is 5 out of 8 which is considered Unsafe as per our analyses.
• A safety Score of 5 indicates that usage of EINECS 255-706-3 may cause serious side effects in breastfed baby.
• Our study of different scientific research indicates that EINECS 255-706-3 may cause moderate to high side effects or may affect milk supply in lactating mother.
• Our suggestion is to use safer alternate options rather than using EINECS 255-706-3 .
• It is recommended to evaluate the advantage of not breastfeeding while using EINECS 255-706-3 Vs not using EINECS 255-706-3 And continue breastfeeding.
• While using EINECS 255-706-3 Its must to monitor child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
• Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

No adverse effects have been reported, but check-up for the possibility of sedation, hypotension, hypoglycemia or bradycardia.

Because of its relatively extensive excretion into breastmilk and its renal excretion, other beta-adrenergic blocking drugs are preferred to EINECS 255-706-3, especially while nursing a newborn or preterm infant.

Relevant published information on EINECS 255-706-3 was not found as of the revision date. A study of mothers taking beta-blockers during nursing found a numerically, but not statistically significant increased number of adverse reactions in those taking any beta-blocker. Although the ages of infants were matched to control infants, the ages of the affected infants were not stated. None of the mothers were taking EINECS 255-706-3.[6]

Relevant published information on the effects of beta-blockade or EINECS 255-706-3 during normal lactation was not found as of the revision date. A study in 6 patients with hyperprolactinemia and galactorrhea found no changes in serum prolactin levels following beta-adrenergic blockade with propranolol.[7]